Sutro Biopharma, Inc. financial data

Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
111 Oyster Point Blvd., South San Francisco, California
Fiscal year end
December 31
Former names
Fundamental Applied Biology Inc (to 10/24/2007)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 425 % -24.6%
Debt-to-equity 250 % +134%
Return On Equity -97.2 % -34%
Return On Assets -27.7 % +20.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82M shares +35.4%
Common Stock, Shares, Outstanding 81.9M shares +35.4%
Entity Public Float 278M USD +11%
Common Stock, Value, Issued 82K USD +36.7%
Weighted Average Number of Shares Outstanding, Basic 81.2M shares +34.6%
Weighted Average Number of Shares Outstanding, Diluted 81.2M shares +34.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD +198%
Research and Development Expense 218M USD +40.1%
General and Administrative Expense 57.2M USD -4.52%
Operating Income (Loss) -106M USD +33.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107M USD +24.9%
Income Tax Expense (Benefit) 8K USD -94.7%
Net Income (Loss) Attributable to Parent -124M USD +12.8%
Earnings Per Share, Basic -1.83 USD/shares +25.3%
Earnings Per Share, Diluted -1.83 USD/shares +25.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 90.8M USD -61.4%
Marketable Securities, Current 285M USD +131%
Accounts Receivable, after Allowance for Credit Loss, Current 6.95M USD -30.5%
Assets, Current 443M USD +7.64%
Property, Plant and Equipment, Net 19.4M USD -17.9%
Operating Lease, Right-of-Use Asset 20.3M USD -19.1%
Other Assets, Noncurrent 4.96M USD +51.9%
Assets 489M USD +5.19%
Accounts Payable, Current 6.09M USD +57.8%
Accrued Liabilities, Current 9.94M USD +4.53%
Contract with Customer, Liability, Current 74M USD +310%
Liabilities, Current 130M USD +93.6%
Contract with Customer, Liability, Noncurrent 21.7M USD -72.8%
Operating Lease, Liability, Noncurrent 19.6M USD -26.1%
Other Liabilities, Noncurrent 1.69M USD
Liabilities 337M USD +8.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -163K USD -1119%
Retained Earnings (Accumulated Deficit) -666M USD -23%
Stockholders' Equity Attributable to Parent 152M USD -1.64%
Liabilities and Equity 489M USD +5.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -64.7M USD -6.15%
Net Cash Provided by (Used in) Financing Activities -3.43M USD -139%
Net Cash Provided by (Used in) Investing Activities 64.1M USD -4.96%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 81.9M shares +35.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.07M USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.6M USD -61.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 63K USD -84%
Deferred Tax Assets, Valuation Allowance 168M USD +27.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 181M USD +27%
Operating Lease, Liability 26.5M USD -18.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -125M USD +11.8%
Lessee, Operating Lease, Liability, to be Paid 31.5M USD -22.3%
Property, Plant and Equipment, Gross 64.1M USD +2.52%
Operating Lease, Liability, Current 6.93M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.99M USD -5.65%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.53M USD +3.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.97M USD -38.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.29M USD -7.84%
Deferred Tax Assets, Operating Loss Carryforwards 37.2M USD -38.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.73M USD +0.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.29M USD -7.84%
Operating Lease, Payments 2.3M USD +35.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.76M USD +9.04%
Deferred Tax Assets, Net of Valuation Allowance 13.1M USD +17.3%
Share-based Payment Arrangement, Expense 24.5M USD -3.41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%